AR015105A1 - Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende - Google Patents

Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende

Info

Publication number: AR015105A1
Authority: AR; Argentina
Prior art keywords: growth; neurites; stimulate; understands; medicine
Prior art date: 1996-11-13

Application number

ARP970105320A

Other languages

English (en)

Spanish (es)

Original Assignee

Vertex Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-13

Filing date

1997-11-13

Publication date

2001-04-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25012320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015105(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-11-13 Application filed by Vertex Pharma filed Critical Vertex Pharma

2001-04-18 Publication of AR015105A1 publication Critical patent/AR015105A1/es

Links

108010025020 Nerve Growth Factor Proteins 0.000 title abstract 5
239000000203 mixture Substances 0.000 title abstract 5
102000007072 Nerve Growth Factors Human genes 0.000 title abstract 3
239000003900 neurotrophic factor Substances 0.000 title abstract 3
210000002241 neurite Anatomy 0.000 title abstract 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
239000004202 carbamide Substances 0.000 title 1
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 title 1
210000004027 cell Anatomy 0.000 title 1
102000015336 Nerve Growth Factor Human genes 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
229940053128 nerve growth factor Drugs 0.000 abstract 2
210000002569 neuron Anatomy 0.000 abstract 2
208000014674 injury Diseases 0.000 abstract 1
230000003961 neuronal insult Effects 0.000 abstract 1
230000000508 neurotrophic effect Effects 0.000 abstract 1
230000008733 trauma Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

ARP970105320A 1996-11-13 1997-11-13 Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende AR015105A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/749,114 US5780484A (en)	1996-11-13	1996-11-13	Methods for stimulating neurite growth with piperidine compounds

Publications (1)

Publication Number	Publication Date
AR015105A1 true AR015105A1 (es)	2001-04-18

Family

ID=25012320

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP970105320A AR015105A1 (es)	1996-11-13	1997-11-13	Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende

Country Status (19)

Country	Link
US (1)	US5780484A (2)
EP (2)	EP1666053A1 (2)
JP (1)	JP2001503778A (2)
KR (1)	KR100537866B1 (2)
CN (1)	CN1168443C (2)
AR (1)	AR015105A1 (2)
AU (1)	AU741186B2 (2)
BR (1)	BR9713037A (2)
CA (1)	CA2270985A1 (2)
CO (1)	CO5080733A1 (2)
EA (1)	EA003530B1 (2)
IL (1)	IL129557A0 (2)
IN (1)	IN183409B (2)
NZ (1)	NZ335396A (2)
PL (1)	PL191249B1 (2)
TW (1)	TW509572B (2)
UA (1)	UA61090C2 (2)
WO (1)	WO1998020893A1 (2)
ZA (1)	ZA9710248B (2)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6150527A (en) *	1994-08-18	2000-11-21	Ariad Pharmaceuticals, Inc.	Synthetic multimerizing agents
US6133456A (en) *	1994-08-18	2000-10-17	Ariad Gene Therapeutics, Inc.	Synthetic multimerizing agents
US20030036654A1 (en) *	1994-08-18	2003-02-20	Holt Dennis A.	Synthetic multimerizing agents
US5859031A (en)	1995-06-07	1999-01-12	Gpi Nil Holdings, Inc.	Small molecule inhibitors of rotamase enzyme activity
US6242468B1 (en) *	1997-02-27	2001-06-05	Jia-He Li	Carbamate and urea compositions and neurotrophic uses
ZA98825B (en) *	1997-02-27	1998-10-19	Guilford Pharm Inc	Method of using neurotrophic carbamates and ureas
US6514686B2 (en)	1997-04-28	2003-02-04	The University Of British Columbia	Method and composition for modulating amyloidosis
US5945441A (en)	1997-06-04	1999-08-31	Gpi Nil Holdings, Inc.	Pyrrolidine carboxylate hair revitalizing agents
US20010049381A1 (en)	1997-06-04	2001-12-06	Gpl Nil Holdings, Inc.,	Pyrrolidine derivative hair growth compositions and uses
US6852496B1 (en)	1997-08-12	2005-02-08	Oregon Health And Science University	Methods of screening for agents that promote nerve cell growth
US5968921A (en)	1997-10-24	1999-10-19	Orgegon Health Sciences University	Compositions and methods for promoting nerve regeneration
PL348671A1 (en) *	1998-06-03	2002-06-03	Gpi Nil Holdings	Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
US6331537B1 (en)	1998-06-03	2001-12-18	Gpi Nil Holdings, Inc.	Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
WO1999062880A1 (en)	1998-06-03	1999-12-09	Gpi Nil Holdings, Inc.	N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
IL140676A0 (en)	1998-07-17	2002-02-10	Agouron Pharma	Compounds, compositions, and methods for stimulating neuronal growth and elongation
GB9815880D0 (en)	1998-07-21	1998-09-16	Pfizer Ltd	Heterocycles
US7338976B1 (en) *	1998-08-14	2008-03-04	Gpi Nil Holdings, Inc.	Heterocyclic esters or amides for vision and memory disorders
US6376517B1 (en) *	1998-08-14	2002-04-23	Gpi Nil Holdings, Inc.	Pipecolic acid derivatives for vision and memory disorders
US6395758B1 (en)	1998-08-14	2002-05-28	Gpi Nil Holdings, Inc.	Small molecule carbamates or ureas for vision and memory disorders
US6462072B1 (en)	1998-09-21	2002-10-08	Gpi Nil Holdings, Inc.	Cyclic ester or amide derivatives
US6228872B1 (en)	1998-11-12	2001-05-08	Bristol-Myers Squibb Company	Neurotrophic diamide and carbamate agents
WO2001002368A1 (en) *	1999-07-06	2001-01-11	Vertex Pharmaceuticals Incorporated	N-heterocyclic derivatives with neuronal activity
RU2241709C2 (ru)	1999-07-09	2004-12-10	Орто-Макнейл Фармасьютикал, Инк.	Производные азотсодержащих гетероциклических соединений и способ лечения расстройств, характеризующихся поражением нейронов
US6734211B1 (en) *	1999-07-09	2004-05-11	Oregon Health & Sciences University	Compositions and methods for promoting nerve regeneration
AU7353300A (en)	1999-09-08	2001-04-10	Guilford Pharmaceuticals Inc.	Non-peptidic cyclophilin binding compounds and their use
US6417189B1 (en)	1999-11-12	2002-07-09	Gpi Nil Holdings, Inc.	AZA compounds, pharmaceutical compositions and methods of use
ATE335524T1 (de) *	1999-11-12	2006-09-15	Alcon Inc	Verwendung von neurophilin liganden zur behandlung von augenerkrankungen
US7253169B2 (en)	1999-11-12	2007-08-07	Gliamed, Inc.	Aza compounds, pharmaceutical compositions and methods of use
US6818643B1 (en)	1999-12-08	2004-11-16	Bristol-Myers Squibb Company	Neurotrophic bicyclic diamides
EP1244670B1 (en)	1999-12-21	2006-03-08	MGI GP, Inc.	Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
MXPA03006666A (es)	2001-01-25	2004-05-31	Guilford Pharm Inc	Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
EP1404325A2 (en) *	2001-05-29	2004-04-07	Guilford Pharmaceuticals Inc.	Method for treating nerve injury caused by surgery
US20040147433A1 (en) *	2001-06-14	2004-07-29	Marcus Keep	Neuroimmunophilins for selective neuronal radioprotection
US6635892B2 (en) *	2002-01-24	2003-10-21	Pei Electronics, Inc.	Compact integrated infrared scene projector
MXPA05003471A (es) *	2002-10-03	2005-07-01	Vertex Pharma	Derivados de piperazina y piperadina para el tratamiento de enfermedades neurologicas.
US20060189551A1 (en) *	2004-10-04	2006-08-24	Duke University	Combination therapies for fungal pathogens
SG158143A1 (en) *	2004-12-20	2010-01-29	Wyeth Corp	Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
RU2007119585A (ru) *	2004-12-20	2009-01-27	Вайет (Us)	Производные рапамицина и их применение при лечении неврологических заболеваний
MX2007010076A (es) *	2005-02-17	2007-10-16	Astellas Pharma Inc	Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo.
CA2637707A1 (en) *	2006-02-02	2007-08-09	Rinat Neuroscience Corporation	Methods for treating obesity by administering a trkb antagonist
CN101400367A (zh) *	2006-02-02	2009-04-01	瑞纳神经科学公司	施用trkb激动剂治疗不希望的重量减轻或进食障碍的方法
JP2021525737A (ja)	2018-05-30	2021-09-27	ザップサージカルシステムズ，インコーポレイテッド	重要構造近くにおける放射線外科的神経調節
CN116763768B (zh) *	2022-03-15	2026-03-20	润佳（苏州）医药科技有限公司	同位素富集的3-氨基-1-丙磺酸衍生物及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5192773A (en) *	1990-07-02	1993-03-09	Vertex Pharmaceuticals, Inc.	Immunosuppressive compounds
HU217621B (hu) *	1991-05-09	2000-03-28	Vertex Pharmaceuticals Inc.	Eljárás új glioxaloil-pipekolinsav-észterek, származékaik és az ezeket tartalmazó gyógyszerkészítmények előállítására
NZ314207A (en) *	1992-09-28	2000-12-22	Vertex Pharma	1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
US5744485A (en) *	1994-03-25	1998-04-28	Vertex Pharmaceuticals Incorporated	Carbamates and ureas as modifiers of multi-drug resistance
IL115685A (en) *	1994-11-16	2000-08-31	Vertex Pharma	Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5543423A (en) *	1994-11-16	1996-08-06	Vertex Pharmaceuticals, Incorporated	Amino acid derivatives with improved multi-drug resistance activity
US5726184A (en) *	1995-05-19	1998-03-10	Vertex Pharmaceuticals Incorporated	Tetralin compounds with improved MDR activity
US5614547A (en) *	1995-06-07	1997-03-25	Guilford Pharmaceuticals Inc.	Small molecule inhibitors of rotamase enzyme
US5696135A (en) *	1995-06-07	1997-12-09	Gpi Nil Holdings, Inc.	Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) *	1995-06-07	1999-01-12	Gpi Nil Holdings, Inc.	Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) *	1995-06-08	2000-03-14	Vertex Pharmaceuticals Incorporated	Methods and compositions for stimulating neurite growth
US5801197A (en) *	1995-10-31	1998-09-01	Gpi Nil Holdings, Inc.	Rotamase enzyme activity inhibitors
US5840736A (en) *	1996-11-13	1998-11-24	Vertex Pharmaceuticals Incorporated	Methods and compositions for stimulating neurite growth
US5811434A (en) *	1996-11-13	1998-09-22	Vertex Pharmacueticals Incorporated	Methods and compositions for stimulating neurite growth
CN104718162B (zh) *	2012-09-28	2017-11-21	Dic株式会社	α‑氧化铝微粒以及其制造方法

1996
- 1996-11-13 US US08/749,114 patent/US5780484A/en not_active Expired - Lifetime
1997
- 1997-11-13 WO PCT/US1997/020868 patent/WO1998020893A1/en not_active Ceased
- 1997-11-13 CA CA002270985A patent/CA2270985A1/en not_active Abandoned
- 1997-11-13 TW TW086116912A patent/TW509572B/zh not_active IP Right Cessation
- 1997-11-13 IN IN2147CA1997 patent/IN183409B/en unknown
- 1997-11-13 AU AU54397/98A patent/AU741186B2/en not_active Ceased
- 1997-11-13 UA UA99063269A patent/UA61090C2/uk unknown
- 1997-11-13 PL PL333286A patent/PL191249B1/pl not_active IP Right Cessation
- 1997-11-13 BR BR9713037-0A patent/BR9713037A/pt not_active Application Discontinuation
- 1997-11-13 JP JP52286798A patent/JP2001503778A/ja active Pending
- 1997-11-13 EP EP06000328A patent/EP1666053A1/en not_active Ceased
- 1997-11-13 CO CO97066753A patent/CO5080733A1/es unknown
- 1997-11-13 AR ARP970105320A patent/AR015105A1/es not_active Application Discontinuation
- 1997-11-13 NZ NZ335396A patent/NZ335396A/xx unknown
- 1997-11-13 EA EA199900463A patent/EA003530B1/ru not_active IP Right Cessation
- 1997-11-13 KR KR10-1999-7004194A patent/KR100537866B1/ko not_active Expired - Fee Related
- 1997-11-13 EP EP97948309A patent/EP0941113A1/en not_active Ceased
- 1997-11-13 CN CNB971802483A patent/CN1168443C/zh not_active Expired - Fee Related
- 1997-11-13 IL IL12955797A patent/IL129557A0/xx not_active IP Right Cessation
- 1997-11-13 ZA ZA9710248A patent/ZA9710248B/xx unknown

Also Published As

Publication number	Publication date
WO1998020893A1 (en)	1998-05-22
NZ335396A (en)	2000-11-24
IN183409B (2)	1999-12-25
PL191249B1 (pl)	2006-04-28
EA199900463A1 (ru)	2000-02-28
KR20000068964A (ko)	2000-11-25
US5780484A (en)	1998-07-14
CN1239434A (zh)	1999-12-22
EP1666053A1 (en)	2006-06-07
CA2270985A1 (en)	1998-05-22
EA003530B1 (ru)	2003-06-26
ZA9710248B (en)	1998-05-28
AU5439798A (en)	1998-06-03
AU741186B2 (en)	2001-11-22
KR100537866B1 (ko)	2005-12-21
IL129557A0 (en)	2000-02-29
CO5080733A1 (es)	2001-09-25
JP2001503778A (ja)	2001-03-21
BR9713037A (pt)	2000-04-11
PL333286A1 (en)	1999-11-22
EP0941113A1 (en)	1999-09-15
TW509572B (en)	2002-11-11
UA61090C2 (uk)	2003-11-17
CN1168443C (zh)	2004-09-29

Legal Events

Date	Code	Title	Description
2010-05-18	FC	Refusal

Publication	Publication Date	Title
AR013873A1 (es)	2001-01-31	Una composicion que comprende derivados de tetralina y factores ico neurologicos para estimular el crecimiento de neuritas en celulas nerviosas
TR199901034T2 (xx)	1999-07-21	N�rit b�y�mesinin uyar�lmas� i�in y�ntemler ve bile�imler.
BR9811923A (pt)	2000-08-15	Compostos possuindo atividade neuronal
NZ335396A (en)	2000-11-24	Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
MX9203653A (es)	1992-09-01	Composiciones amfotericas y formas polimericas de los alfa-hidroxiacidos.
BRPI0511132A (pt)	2007-11-27	derivados de pirimidina e composição farmacêutica compreendendo os mesmos
BR0116402A (pt)	2003-11-11	Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular
ES2154287T3 (es)	2001-04-01	Procedimiento para modificar el crecimiento de los pelos y/o de los cabellos y composiciones utilizables a este efecto.
AR007827A1 (es)	1999-11-24	3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos.
AR001332A1 (es)	1997-10-22	Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
BR0013081A (pt)	2002-04-23	Pirimidino-2,4,6-trionas inibidoras de metaloproteinases
PA8432901A1 (es)	2000-05-24	Compuestos de piridilpirrol
ES2052603T3 (es)	1994-07-16	Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
CO4940451A1 (es)	2000-07-24	Derivados de acido barbiturico con actividad antimetastica y antitumoral
BR9609333A (pt)	1999-10-13	Processos e composições para estimular crescimento de neurite
ATE109793T1 (de)	1994-08-15	Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.
MX9308013A (es)	1994-08-31	4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen.
AR016875A1 (es)	2001-08-01	Un amino-derivado que posee actividad neuronal, una composicion que lo contiene y usos de los mismos para estimular la actividad neuronal
ES2061118T3 (es)	1994-12-01	N-oxidos de piridinas sustituidas en posiciones 2,4 y 2,5, procedimiento para su preparacion, asi como su utilizacion.
DE59906391D1 (de)	2003-08-28	Mittel zum schutz der haut enthaltend hydrolysierte hyaluronsäure
ES8700232A1 (es)	1986-10-01	Un procedimiento para producir 1a,25-dihidroxi-26,27-dime- tilcolecalciferol
ES2038092T1 (es)	1993-07-16	Un compuesto de dioxetano.
ES2055319T3 (es)	1994-08-16	Composiciones quimicas de base acuosa.
DK513384A (da)	1985-04-29	Griseolsyrederivater og deres anvendelse
ES2093944T3 (es)	1997-01-01	Composicion cosmetica y/o dermatologica de accion despigmentante que contiene un acido di- o tri-cafeoilquinico o una mezcla de estos.